Cancer treatment has always been a major focus for the medical community and patients alike. In recent years, a natural ingredient derived from citrus-Modified Citrus Pectin (MCP)-has gradually gained attention for its remarkable potential in supporting cancer treatment. Not only does it inhibit the growth and metastasis of tumors by blocking the Gal-3 protein, but it also enhances immune system function and reduces the side effects of chemotherapy.
What is Modified Citrus Pectin (MCP)?
Modified Citrus Pectin is a water-soluble polysaccharide extracted from citrus peels. Its main component is galacturonic acid, constituting ≥90% of its content, with a molecular weight ranging from 8,000 to 22,000 Da. It boasts excellent biocompatibility and safety, and multiple studies have confirmed its various functions, including anti-tumor properties, detoxification, blood lipid reduction, and improvement of intestinal health.
How Does MCP Combat Cancer?
MCP can specifically bind to and inhibit the Gal-3 protein, a key protein closely associated with tumor formation, development, and metastasis. By blocking Gal-3, MCP can:
Inhibit the growth and spread of cancer cells.
Enhance the activity of immune cells.
Reduce the side effects and drug resistance associated with chemotherapy.
Real Case: Professional Endorsement from a Dutch Doctor
Recently, a customer brought our Modified Citrus Pectin product to a private doctor in the Netherlands for evaluation. After understanding its composition and mechanism, the doctor stated, "This is a very good product that can be used in cancer adjuvant therapy." The customer immediately placed an additional order, demonstrating the recognition of its efficacy by healthcare professionals.
Scientific Research and Clinical Trial Support
Our collaborative research on cancer adjuvant therapy with several institutions, including Zhejiang University and Fudan University, has shown promising progress. Currently, MCP is undergoing clinical trials in Poland and at Guangzhou Cancer Hospital, further validating its potential application in cancer treatment.
Why Choose Our Modified Citrus Pectin?
Our product is primarily supplied to health supplement companies and pharmaceutical companies engaged in anti-cancer drug research. Zhejiang Gold Kropn Biotechnology Co., Ltd. is a national high-tech enterprise integrating scientific research, production, and sales. The company operates a 100,000-grade GMP-certified production facility, utilizing imported lemon peels as raw material and employing advanced enzymatic hydrolysis technology to extract high-purity MCP. Every step of the process-from raw material selection to production-is strictly controlled, adhering to natural ingredients and clean production methods to ensure product safety and superior quality. This commitment to quality and research, in collaboration with leading academic institutions such as Zhejiang University, Fudan University, Tianjin University, and Xinxiang Medical University in Henan, allows the company to actively conduct research on a series of health food products featuring modified citrus pectin. Their products are exported to numerous countries and regions worldwide.
For more information, please contact wilson@zjgykp.com.
Gold Kropn is home to Asia's only dedicated Modified Citrus Pectin production line. We hold 12 Chinese patents and have passed multiple international certifications, including ISO22000 and GMP. Our products are known for their high purity, high activity, and excellent safety profile, making them a reliable companion on your cancer support journey.
If you are looking for a natural, safe, and effective adjuvant product for cancer support, Modified Citrus Pectin (MCP) is worth exploring in depth.